Targeted therapy

October 14, 2019

Trial Results: With E1912, there is a new standard of care for the initial treatment of patients with chronic lymphocytic leukemia

The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.
February 9, 2020
green awareness ribbon hope

Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma

Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
February 12, 2020
crowd of women

Trial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrence

The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
June 24, 2021
MATCH image

Ongoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment option

Each arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.